EODData

MEMBERSHIP REGISTER LOG IN

FRA, 1S1: VIRIDIAN THERAPEUTICS

21 Nov 2025
LAST:

25.25

CHANGE:
 0.57		OPEN:
25.25		HIGH:
25.25		ASK:
0.00		VOLUME:
38
CHG(%):
2.31		PREV:
24.68		LOW:
25.25		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 Nov 2525.2525.2525.2525.2538
20 Nov 2524.6824.6824.6824.6838
19 Nov 2524.3124.3124.3124.3138
18 Nov 2524.6524.6524.6524.6538
17 Nov 2524.4424.4424.4424.4438
13 Nov 2524.6724.6724.6724.6738
12 Nov 2524.2224.2224.2224.2238
11 Nov 2523.5823.5823.5823.5838
07 Nov 2523.5323.5323.5323.5338
06 Nov 2521.2021.2021.2021.2038

PROFILE

Name:VIRIDIAN THERAPEUTICS
About:Viridian Therapeutics, Inc. engages in discovering, developing, and commercializing treatments for serious and rare diseases. The company's product pipeline includes veligrotug, a monoclonal antibody targeting insulin-like growth factor-1 receptor that is in Phase 3 clinical trial for the treatment of thyroid eye disease (TED); and VRDN-003, a next generation IGF-1R monoclonal antibodies targeting IGF-1R and engineered of half-life extension technology, which is in Phase 3 clinical trial for the treatment of TED. It also develops portfolio of engineered anti-neonatal Fc receptor inhibitors, such as VRDN-006 and VRDN-008 for autoimmune disease. The company was formerly known as Miragen Therapeutics, Inc. and changed its name to Viridian Therapeutics, Inc. in January 2021.Viridian Therapeutics, Inc. was founded in 2010 and is headquartered in Waltham, Massachusetts.
Sector:Healthcare
Industry:Biotechnology
Address:221 Crescent Street, Waltham, MA, United States, 02453
Website:https://www.viridiantherapeutics.com
ISIN:US92790C1045
LEI:549300C775BNYF550E70

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-6.45 
Forward P/E:-7.23 
PEG Ratio:3.29 
Price to Sales:5,919.32 
Price to Book:4.79 
Operating Margin:-1,423.56 
Return on Assets:-0.40 
Return on Equity:-0.66 
Revenue:264.7K 
Shares:81.66M 
Market Cap:2.062B 

TECHNICAL INDICATORS

MA5:24.672.4%
MA10:24.055.0%
MA20:21.8115.8%
MA50:19.2031.5%
MA100:16.9948.6%
MA200:14.9469.0%
STO9:100.00 
STO14:100.00 
RSI14:83.20 
MTM14:5.01
ROC14:0.25 
ATR:0.66 
Week High:25.250.0%
Week Low:24.313.9%
Month High:25.250.0%
Month Low:18.5969.0%
Year High:25.250.0%
Year Low:9.58163.5%
Volatility:3.45 

RECENT SPLITS

Date Ratio
13 Nov 20201-15
07 Nov 20161-15